Farther Finance Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$905K Buy
1,450
+224
+18% +$131K 0.01% 1193
2026
Q2
$650K Sell
1,226
-857
-41% -$396K 0.01% 1364
2026
Q1
$1.02M Sell
2,083
-46
-2% -$23.6K 0.01% 952
2025
Q4
$1.2M Buy
2,129
+423
+25% +$240K 0.01% 795
2025
Q3
$877K Sell
1,706
-109
-6% -$47.6K 0.01% 786
2025
Q2
$570K Buy
1,815
+530
+41% +$159K 0.01% 850
2025
Q1
$383K Sell
1,285
-40
-3% -$13.5K 0.01% 922
2024
Q4
$440K Sell
1,325
-176
-12% -$59.7K 0.02% 634
2024
Q3
$501K Buy
1,501
+1,152
+330% +$438K 0.02% 587
2024
Q2
$142K Buy
349
+189
+118% +$74.8K 0.01% 987
2024
Q1
$63.7K Buy
160
+123
+332% +$43.2K ﹤0.01% 1098
2023
Q4
$11.3K Buy
37
+11
+42% +$2.97K ﹤0.01% 1559
2023
Q3
$6.29K Buy
26
+1
+4% +$256 ﹤0.01% 1441
2023
Q2
$6K Hold
25
– – ﹤0.01% 1366
2023
Q1
$4.7K Hold
25
– – ﹤0.01% 1364
2022
Q4
$5.31K Buy
+25
New +$5K ﹤0.01% 1149

Other funds holding MEDP

Farther Finance Advisors's MEDP Position: Q3 2026 in Review

Farther Finance Advisors increased its Medpace (MEDP) stake by 18% in Q3 2026, buying an estimated $131K and bringing the position to 1,450 shares worth $905K. The position accounts for 0.01% of the portfolio, ranked #1193.

Farther Finance Advisors first reported a position in MEDP in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.2M in Q4 2025. 22 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Farther Finance Advisors held 1,450 shares of Medpace worth $905K as of Q3 2026.
  • Farther Finance Advisors bought 224 Medpace shares in Q3 2026, an estimated $131K.
  • Medpace made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1193 holding.
  • Farther Finance Advisors first reported a position in Medpace in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Medpace position peaked at $1.2M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.